A recent clinical trial reported in The Lancet Respiratory Medicine shows that the protein Interferon Beta 1a when inhaled, reduces the chances of hospitalized early-stage Covid-19 patients becoming severely ill or dying. The investigators conducted a randomized, double-blind placebo-controlled phase II clinical trial at nine sites in the UK. The trial was done with 98 [...]
